Stryker Corporation (SYK) Shares Sold by Norris Perne & French LLP MI
Norris Perne & French LLP MI decreased its holdings in Stryker Corporation (NYSE:SYK) by 3.0% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 20,071 shares of the medical technology company’s stock after selling 625 shares during the quarter. Norris Perne & French LLP MI’s holdings in Stryker Corporation were worth $2,850,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also modified their holdings of the company. Acrospire Investment Management LLC bought a new position in Stryker Corporation in the 2nd quarter valued at $111,000. Motco raised its position in Stryker Corporation by 50.7% in the 2nd quarter. Motco now owns 826 shares of the medical technology company’s stock valued at $115,000 after purchasing an additional 278 shares during the last quarter. Bollard Group LLC raised its position in Stryker Corporation by 0.4% in the 2nd quarter. Bollard Group LLC now owns 832 shares of the medical technology company’s stock valued at $115,000 after purchasing an additional 3 shares during the last quarter. Bruderman Asset Management LLC bought a new position in Stryker Corporation in the 2nd quarter valued at $150,000. Finally, James Investment Research Inc. bought a new position in Stryker Corporation in the 2nd quarter valued at $155,000. Hedge funds and other institutional investors own 74.13% of the company’s stock.
COPYRIGHT VIOLATION WARNING: This news story was originally posted by Watch List News and is the sole property of of Watch List News. If you are reading this news story on another domain, it was illegally stolen and republished in violation of U.S. & international copyright legislation. The original version of this news story can be read at https://www.watchlistnews.com/stryker-corporation-syk-shares-sold-by-norris-perne-french-llp-mi/1685603.html.
Shares of Stryker Corporation (NYSE:SYK) traded up $0.02 during trading on Tuesday, hitting $156.20. The company had a trading volume of 20,847 shares, compared to its average volume of 1,220,000. The company has a current ratio of 2.37, a quick ratio of 1.61 and a debt-to-equity ratio of 0.63. Stryker Corporation has a twelve month low of $106.48 and a twelve month high of $160.62. The firm has a market capitalization of $58,250.00, a PE ratio of 24.75, a PEG ratio of 2.46 and a beta of 0.79.
Stryker Corporation (NYSE:SYK) last posted its earnings results on Thursday, October 26th. The medical technology company reported $1.52 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.50 by $0.02. Stryker Corporation had a return on equity of 24.11% and a net margin of 14.67%. The firm had revenue of $3.01 billion during the quarter, compared to analysts’ expectations of $2.97 billion. During the same period in the previous year, the firm earned $1.39 earnings per share. The company’s revenue was up 6.1% on a year-over-year basis. research analysts predict that Stryker Corporation will post 6.47 earnings per share for the current fiscal year.
Several equities analysts have issued reports on the company. Cowen and Company set a $166.00 price objective on Stryker Corporation and gave the company a “buy” rating in a research report on Sunday, October 29th. Needham & Company LLC reiterated a “hold” rating on shares of Stryker Corporation in a research report on Friday. Oppenheimer Holdings, Inc. set a $156.00 price objective on Stryker Corporation and gave the company a “hold” rating in a research report on Monday, October 30th. Zacks Investment Research upgraded Stryker Corporation from a “sell” rating to a “hold” rating in a research report on Tuesday, October 24th. Finally, Barclays PLC lifted their price objective on Stryker Corporation from $137.00 to $148.00 and gave the company an “underweight” rating in a research report on Friday, October 27th. Two equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and twelve have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average price target of $151.52.
In other Stryker Corporation news, insider Lonny J. Carpenter sold 5,000 shares of the business’s stock in a transaction dated Friday, November 3rd. The stock was sold at an average price of $155.34, for a total value of $776,700.00. Following the completion of the transaction, the insider now directly owns 83,207 shares of the company’s stock, valued at $12,925,375.38. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 7.40% of the stock is currently owned by insiders.
Stryker Corporation Profile
Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.
Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK).
Receive News & Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.